首页> 外国专利> Alogliptin in any form as protected by the basic patent, combined with metformin all forms as protected by the basic patent

Alogliptin in any form as protected by the basic patent, combined with metformin all forms as protected by the basic patent

机译:基本专利保护的任何形式的阿格列汀,与基本专利保护的所有形式的二甲双胍合用

摘要

Pharmaceutical compositions comprising 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1 (2H)-pyrimidinyl]methyl]-benzonitrile and pharmaceutically acceptable salts thereof are provided as well as kits and articles of manufacture comprising the pharmaceutical compositions as well as methods of using the pharmaceutical compositions.
机译:包含2-[[[6-[(3R)-3-氨基-1-哌啶基] -3,4-二氢-3-甲基-2,4-二氧杂-1(2H)-嘧啶基]甲基]-苄腈的药物组合物本发明提供了其药学上可接受的盐以及包含该药物组合物的试剂盒和制品以及使用该药物组合物的方法。

著录项

  • 公开/公告号LU92375I2

    专利类型

  • 公开/公告日2015-10-29

    原文格式PDF

  • 申请/专利权人 TAKEDA PHARMACEUTICAL COMPANY LIMITED;

    申请/专利号LU20140092375C

  • 发明设计人

    申请日2014-02-12

  • 分类号C07D209/12;A61K31/335;A61K31/34;A61K31/341;A61K31/343;A61K31/395;A61K31/403;A61K31/4035;A61K31/404;A61K31/405;A61K31/415;A61K31/42;A61K31/421;A61K31/425;A61K31/535;A61K31/5377;A61P3;A61P11/08;A61P25/04;A61P29;A61P37/08;C07C257/06;C07C259/04;C07C317/40;C07D207/337;C07D209/26;C07D209/46;C07D209/82;C07D231/12;C07D263/32;C07D263/46;C07D277;C07D279;C07D307/72;C07D307/92;C07D313/12;C07D487/04;C07D491/044;C07D491/052;C07D495/04;

  • 国家 LU

  • 入库时间 2022-08-21 15:14:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号